Im Ellie Eunkyung — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Im Ellie Eunkyung has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $22K.
Profile
Ellie Eunkyung Im (often listed in filings as Im Ellie Eunkyung) is a biotechnology executive who, as of the SEC filing date of 2026-06-23, serves as Chief Medical Officer of Crescent Biopharma, Inc. In the role of Chief Medical Officer, she would typically be responsible for medical strategy, clinical development programs, medical affairs, and regulatory interactions. The provided SEC context confirms Crescent Biopharma, Inc. as her employer, but there is limited publicly available information in this context about her prior roles, education, or detailed career history. This biography is based on the SEC filing context you provided and is intended to reflect her cited position and company affiliation.
Ellie Eunkyung Im (often listed in filings as Im Ellie Eunkyung) is a biotechnology executive who, as of the SEC filing date of 2026-06-23, serves as Chief Medical Officer of Crescent Biopharma, Inc. In the role of Chief Medical Officer, she would typically be responsible for medical strategy, clinical development programs, medical affairs, and regulatory interactions. The prov…
How many SEC Form 4 filings has Im Ellie Eunkyung submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has Im Ellie Eunkyung been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($22K) across all tracked filings.
Where can I see all of Im Ellie Eunkyung's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
